IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...

Cryoablation in most cases only requires local anesthetic and can be completed within an hour.

IceCure sponsored a cryoablation symposium led by Key Opinion Leader breast physicians from leading medical institutions including Cleveland Clinic, University of Michigan, West Cancer Center, and the ...

The FDA has approved cryoablation — a procedure that freezes and kills small breast tumors without surgery — for women over 70 with low-risk cancer, though some experts question whether it prevents ...

The approach is particularly suited to patients who are not fit for major surgery due to having only one functioning kidney.

AtriCure (NASDAQ:ATRC) executives said the company’s 2026 revenue outlook is being supported by recent and upcoming product launches, continued adoption of its EnCompass ablation platform and ...

The approach is particularly suited to patients who are not fit for major surgery due to having only one functioning kidney.

IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, ...

Pent-up demand immediately following FDA clearance generates 46% increase in active customer accounts using ProSense® as of the end of the first quarter 2026, compared ...

CHICAGO, IL—Cryoablation delivered at temperatures as low as -120°C keeps most patients with monomorphic ventricular tachycardia (VT) free from recurrent episodes at 6 months, according to results ...